FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> H5N1   Novavax   Clinical Trial Results   Vaccine
Syndicate content

preclinical News

Most Popular preclinical Story

Novavax VLP vax works against 1918 Spanish flu

Novavax says that a virus-like particle vaccine it developed was successful in guarding against both the deadly 1918 Spanish flu strain as well as an H5N1 strain in a preclinical study. Researchers Read more...

preclinical Press Releases

  • Novavax Announces Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against H1N1 and H5N1
  • ReNeuron announces positive pre-clinical data with lead stem cell line in peripheral arterial disease
  • Alkermes Presents Positive Preclinical Data on Molecule Designed to Improve Outcomes for Patients Taking Opiod Analgesics
  • Ardea Biosciences's MEK Inhibitor, RDEA119, Demonstrates Synergy with Other Anti-Cancer Agents in Multiple Tumor Types
  • Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies

Latest Headlines

  • Novavax VLP vax works against 1918 Spanish flu
    April 16, 2009